Intravenous Infusions Plc (GHSE:IIL)

Intravenous Infusions Statistics

Total Valuation

GHSE:IIL has a market cap or net worth of GHS 13.72 million. The enterprise value is 23.47 million.

Market Cap	13.72M
Enterprise Value	23.47M

Important Dates

The next estimated earnings date is Wednesday, June 10, 2026.

Earnings Date	Jun 10, 2026
Ex-Dividend Date	n/a

Share Statistics

GHSE:IIL has 274.41 million shares outstanding.

Current Share Class	274.41M
Shares Outstanding	274.41M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+5.26%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.47
PB Ratio	1.22
P/TBV Ratio	1.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.07
EV / Sales	2.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-26.89

Financial Position

The company has a current ratio of 0.56, with a Debt / Equity ratio of 0.87.

Current Ratio	0.56
Quick Ratio	0.34
Debt / Equity	0.87
Debt / EBITDA	n/a
Debt / FCF	-11.19
Interest Coverage	-72.10

Financial Efficiency

Return on equity (ROE) is -34.07% and return on invested capital (ROIC) is -37.84%.

Return on Equity (ROE)	-34.07%
Return on Assets (ROA)	-11.85%
Return on Invested Capital (ROIC)	-37.84%
Return on Capital Employed (ROCE)	-47.74%
Weighted Average Cost of Capital (WACC)	3.25%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.22
Inventory Turnover	1.51

Taxes

Income Tax	-1.15M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.12
52-Week Price Change	n/a
50-Day Moving Average	0.05
200-Day Moving Average	0.06
Relative Strength Index (RSI)	54.61
Average Volume (20 Days)	112,550

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GHSE:IIL had revenue of GHS 9.30 million and -4.63 million in losses. Loss per share was -0.02.

Revenue	9.30M
Gross Profit	1.31M
Operating Income	-7.96M
Pretax Income	-5.78M
Net Income	-4.63M
EBITDA	-7.41M
EBIT	-7.96M
Loss Per Share	-0.02

Balance Sheet

The company has 20,887 in cash and 9.77 million in debt, with a net cash position of -9.75 million or -0.04 per share.

Cash & Cash Equivalents	20,887
Total Debt	9.77M
Net Cash	-9.75M
Net Cash Per Share	-0.04
Equity (Book Value)	11.28M
Book Value Per Share	0.04
Working Capital	-9.88M

Cash Flow

In the last 12 months, operating cash flow was -342,900 and capital expenditures -529,807, giving a free cash flow of -872,707.

Operating Cash Flow	-342,900
Capital Expenditures	-529,807
Depreciation & Amortization	548,512
Net Borrowing	-466,155
Free Cash Flow	-872,707
FCF Per Share	-0.00

Margins

Gross margin is 14.07%, with operating and profit margins of -85.52% and -49.78%.

Gross Margin	14.07%
Operating Margin	-85.52%
Pretax Margin	-62.11%
Profit Margin	-49.78%
EBITDA Margin	-79.63%
EBIT Margin	-85.52%
FCF Margin	n/a

Dividends & Yields

GHSE:IIL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-33.76%
FCF Yield	-6.36%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GHSE:IIL has an Altman Z-Score of -0.53 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.53
Piotroski F-Score	1